Phreesia/$PHR
1D1W1M3M6MYTD1Y5YMAX
Capital at risk
About Phreesia
Phreesia Inc is a provides an integrated software, payments, and engagement platform designed to address three foundational challenges in healthcare delivery: access to care, affordability of care, and patient health outcomes. Its platform is embedded directly into provider workflows and patient interactions, enabling healthcare organizations to activate patients, streamline administrative processes, and improve financial performance across the care continuum. The group serves a diverse group of healthcare organizations, including ambulatory practices, health systems, and hospitals, as well as life sciences companies, government entities, patient advocacy, public interest, and not-for-profit and other organizations.
- Ticker
- $PHR
- Sector
- Health
- Primary listing
- NYSE
- Employees
- 1,789
- Headquarters
- Wilmington, United States
- Website
- www.phreesia.com
Phreesia Metrics
BasicAdvanced
$783M
73.47
$0.17
0.86
-
Price and volume
Market cap
$783M
Beta
0.86
52-week high
$23.31
52-week low
$7.77
Average daily volume
645K
Financial strength
Current ratio
1.762
Quick ratio
1.441
Long term debt to equity
0.166
Total debt to equity
0.183
Interest coverage (TTM)
2.50%
Profitability
EBITDA (TTM)
43.76
Gross margin (TTM)
67.57%
Net profit margin (TTM)
2.06%
Operating margin (TTM)
5.01%
Effective tax rate (TTM)
-277.97%
Revenue per employee (TTM)
$280,000
Management effectiveness
Return on assets (TTM)
3.01%
Return on equity (TTM)
3.12%
Valuation
Price to earnings (TTM)
73.467
Price to revenue (TTM)
1.511
Price to book
2.11
Price to tangible book (TTM)
10.91
Price to free cash flow (TTM)
11.367
Free cash flow yield (TTM)
8.80%
Free cash flow per share (TTM)
1.11
Growth
Revenue change (TTM)
12.93%
Earnings per share change (TTM)
-140.94%
3-year revenue growth (CAGR)
16.72%
3-year earnings per share growth (CAGR)
-60.88%
What the Analysts think about Phreesia
Analyst ratings (Buy, Hold, Sell) for Phreesia stock.
Analyst projections of the future price of Phreesia stock.
Bulls say / Bears say
Second-quarter revenue rose 10% year on year, with healthcare-services clients up 6% and revenue per client up 4%. Adjusted EBITDA and free cash flow also increased, showing growth alongside improving profitability and cash generation. (Phreesia)
A customer case study reported that Effingham Health System lifted time-of-service collections by 55% and had 89% of patients check themselves in after adopting Phreesia. Demonstrable operational and financial benefits could help the company win and expand provider relationships. (Phreesia)
Phreesia increased AccessOne’s financing facility from $200 million to $300 million, widening its capacity to offer patient financing to more provider clients. The company expects AccessOne to contribute about $37 million to fiscal 2027 revenue, giving this newer offering a meaningful near-term growth role. (Phreesia)
Phreesia said some Network Solutions clients had committed to lower spending for the second half of fiscal 2027, citing brand-specific factors including regulatory policies. It also warned that revenue in this segment is harder to forecast, creating a risk to growth and guidance. (Phreesia, Phreesia)
Subscription and related-services revenue fell about 2% year on year in the second quarter, even as total revenue grew 10%. That leaves growth more reliant on payments and Network Solutions while the subscription line is contracting. (SEC)
Phreesia identifies electronic health record and practice-management providers as competitors, including systems with which it integrates. If it cannot compete effectively, those vendors could weaken its growth and financial results. (SEC)
Data summarised monthly by Lightyear AI. Last updated on 27 Oct 2026.
Phreesia Financial Performance
Revenues and expenses
Phreesia Earnings Performance
Company profitability
Upcoming events
No upcoming events
Phreesia News
AllArticlesVideos
Phreesia's Michael Rasbury Named to Becker's 2026 List of Rising Stars: Healthcare Leaders Under 40
Business Wire4 weeks ago
Phreesia Named to TIME's 2026 List of the World's Top HealthTech Companies
Business Wire1 month ago
Phreesia's ProviderConnect Audiences are Now Available in the DeepIntent Audience Marketplace
Business Wire2 months ago
Funds containing Phreesia
Fund name | Fund size | $PHR weighting |
|---|---|---|
SPDR Russell 2000 US Small Cap€R2US | $5.3B | 0.02% |
SPDR Russell 2000 US Small Cap£R2SC | $5.3B | 0.02% |
iShares MSCI World Small Cap€IUSN | $9B | 0.01% |
iShares MSCI World Small Cap$WSML | $9B | 0.01% |
iShares MSCI World Small Cap£WLDS | $9B | 0.01% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.